Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 13 Jan 2025

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models

in Cancer Immunity and Immunotherapy

Barry E. Kennedy
Erin B. Noftall
Cheryl Dean
Alexander Roth
Kate N. Clark
Darren Rowles
Kulbir Singh
Len Pagliaro
Carman A. Giacomantonio

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512543

4,341 views

Original Research

Published on 13 Jan 2025

Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages

in Cancer Immunity and Immunotherapy

Tun Kiat Ko
Zexi Guo
Bavani Kannan
Boon Yee Lim
Jing Yi Lee
Zhimei Li
Elizabeth Chun Yong Lee
Bin Tean Teh
Jason Yongsheng Chan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1515935

783 views

Original Research

Published on 13 Jan 2025

Construction of an anaplastic thyroid cancer stratification signature to guide immune therapy selection and validation of the pivotal gene HLF through in vitro experiments

in Cancer Immunity and Immunotherapy

Li Pengping
Yin Kexin
Xie Yuwei
Sun Ke
Li Rongguo
Wang Zhenyu
Jin Haigang
Wang Shaowen
Huang Yuqing

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478904

714 views

Original Research

Published on 13 Jan 2025

Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Zhe Zhao
Dongmei Wang
Xue Sheng
Shuying Li
Tingting Liu
Mengyuan Chang
Lei Feng
Di Zhang
Chunyan Ji
Fei Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429855

692 views

Original Research

Published on 13 Jan 2025

In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma

in Cancer Immunity and Immunotherapy

Zhi Guo
Mingxin He
Ning Liu
Yiqing Yang
Rui Sun
Jianxun Wang
Qiang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1521778

1,042 views

Case Report

Published on 10 Jan 2025

Case report: A successful case of targeted immunotherapy for locally advanced pancreatic cancer under non-surgical conditions

in Cancer Immunity and Immunotherapy

Yuanbo Bi
Haotian Yv
Xiaopeng Ma
Shengxiong Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1519186

729 views

Original Research

Published on 10 Jan 2025

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)

in Cancer Immunity and Immunotherapy

Kuniaki Sato
Satoshi Toh
Taku Murakami
Takafumi Nakano
Takahiro Hongo
Mioko Matsuo
Kazuki Hashimoto
Masashi Sugasawa
Keisuke Yamazaki
Yushi Ueki

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464419

1,076 views

Original Research

Published on 10 Jan 2025

Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer

in Cancer Immunity and Immunotherapy

Chong Shen
Yong Suo
Jian Guo
Wei Su
Zhe Zhang
Shaobo Yang
Zhouliang Wu
Zhenqian Fan
Xiaoliang Zhou
Hailong Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430583

1,365 views

Systematic Review

Published on 10 Jan 2025

Mechanistic exploration of Traditional Chinese Medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis

in Cancer Immunity and Immunotherapy

Dandan Feng
Dongqing Pu
Jinlu Ren
Ming Liu
Xiaohui Sun
Zhen Zhang
Jingwei Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443648

1,227 views

Original Research

Published on 10 Jan 2025

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience

in Cancer Immunity and Immunotherapy

Zizhuo Wang
Songlin Song
Lijie Zhang
Tingting Yang
Wei Yao
Bin Liang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474442

502 views

Original Research

Published on 10 Jan 2025

Development and external validation of a model to predict recurrence in patients with non-muscle invasive bladder cancer

in Cancer Immunity and Immunotherapy

Jiajia Tang
Longmei Fan
Tianyu Huang
Rongrong Yang
Xinqi Yang
Yuanjian Liao
Mingshun Zuo
Neng Zhang
Jiangrong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467527

465 views

Review

Published on 10 Jan 2025

m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon

in Cancer Immunity and Immunotherapy

Yiqi Sun
Yunfei Liu
Lu Jiang
Chao Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512353

810 views

Original Research

Published on 10 Jan 2025

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration

in Cancer Immunity and Immunotherapy

Vinicius Kannen
Marit Rasmussen
Siddhartha Das
Paolo Giuliana
Fauzia N. Izzati
Hani Choksi
Linnea A. M. Erlingsson
Ninni E. Olafsen
Samaneh S. Åhrling
Paola Cappello

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513595

1,079 views

Review

Published on 10 Jan 2025

Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies

in Cancer Immunity and Immunotherapy

Wenjuan Wang
Hong Wang
Qi Wang
Xiaojing Yu
Liangliang Ouyang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513047

1,559 views

Original Research

Published on 10 Jan 2025

Pan-cancer analysis of Arp2/3 complex subunits: focusing on ARPC1A’s role and validating the ARPC1A/c-Myc axis in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Chenkang Zhou
Yuxin Chen
Shuhui Chen
Lijuan Hu
Junjun Wang
Yumin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491910

746 views

Original Research

Published on 10 Jan 2025

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML

in Cancer Immunity and Immunotherapy

Julia Wlosik
Florence Orlanducci
Manon Richaud
Clemence Demerle
Amira Ben Amara
Marie-Sarah Rouviere
Philippe Livrati
Laurent Gorvel
Marie-Anne Hospital
Nicolas Dulphy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487792

916 views

Navigation group

Articles

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models

Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages

Construction of an anaplastic thyroid cancer stratification signature to guide immune therapy selection and validation of the pivotal gene HLF through in vitro experiments

Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia

In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma

Case report: A successful case of targeted immunotherapy for locally advanced pancreatic cancer under non-surgical conditions

Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)

Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer

Mechanistic exploration of Traditional Chinese Medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience

Development and external validation of a model to predict recurrence in patients with non-muscle invasive bladder cancer

m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration

Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies

Pan-cancer analysis of Arp2/3 complex subunits: focusing on ARPC1A’s role and validating the ARPC1A/c-Myc axis in non-small cell lung cancer

CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML